Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H. & Fiers, W. (1987). Evidence for tumour necrosis factorkachectin production in cancer. Lancet ii, 1229–1232.
Ball, H. A., Wick, A. N. & Sanders, C. (1957). Influence of glucose antimetabolites on the Walker tumour. Cancer Research 17,235–239.
Beck, S. A., Smith, K. L. & Tisdale, M. J. (1991). Anticachectic and antitumour effect of eicosapentanoic acid and its effect on protein turnover. Cancer Research 51,6089–4093.
Brennan, M. F. (1977). Uncomplicated starvation versus cancer cachexia. Cancer Research 37,2359–2364.
Brennan, M. F. (1981). Total parenteral nutrition in the cancer patient. New England Journal of Medicine 305, 375–382.
Brooks, S. L., Neveille, A. M., Rothwell, N. J., Stock, M. J & Wilson, S. (1981). Symptomatic activation of brown–adipose–tissue thermogenesis in cachexia. Bioscience Reports 1,509–517.
Burkinshaw, L., Hull, G. L. & Morgan, D. B. (1978). Assessment of the distribution of protein in the human by in vivo neutron activation analysis. International Symposium on Nuclear Activation Techniques in the Life Sciences, International Atomic Energy Authority Publication no. SM–227139, pp. 787–796. Vienna: International Atomic Energy Authority.
Chlebowski, R. T. (1986). Effect of nutritional support on the outcome of anti–neoplastic therapy. In Nutritional Support for the Cancer Patient, pp. 365–379 [Calman, K. C. and Fearon, K. C. H., editors]. London: W. B. Saunders.
Cohn, H. S., Vartsky, D., Shok, N., Sawitsky, A., Rai, K., Gartenhaus, W., Yasmura, S. & Ellis, K. J. (1982). Changes in body composition of cancer patients following combined nutritional support. Nutrition and Cancer 4,107–119.
Conyers, R. A. J., Need, A. G., Durbridge, T., Harvey, N. O. M., Potenzy, N. & Roffe, A. M. (1979). Cancer, ketosis and parenteral nutrition. Medical Journal of Australia 1,398–399.
Cooper, E. H. & Stone, J. (1979). Acute phase reactant proteins in cancer. In Advances in Cancer Research, pp. 1–44 [G., Klein and S., Weinhouse, editors]. New York: Academic Press.
Costa, G., Rowley, P., Aragon, M. & Siebold, J. (1981). Anorexia and weight loss in cancer patients. Cancer Treatment Reports 65, Suppl. 5, 3–7.
Dinarello, C. A. (1984). Interleukin-1 and the pathogenesis of the acute-phase response. New England Journal of Medicine 311,1413–1418.
Di Tullio, N. W., Berkoff, C. E., Blank, B., Kostos, V., Stack, E. J & Saunders, H. L. (1974). 3-Mercaptopicolinic acid, an inhibitor of gluconeogenesis. Biochemical Journal 138.387–394.
Eden, E., Ekman, L., Bennegard, K., Lindmark, L. & Lundholm, K. (1984). Whole body tyrosine flux in relation to energy expenditure in weight-losing cancer patients. Metabolism 33, 1020–1027.
Emery, P. W., Edwards, R. H. J., Rennie, M. J., Souhemi, R. L. & Halliday, D. (1984 a). Protein synthesis in muscle measured in vivo in cachectic patients with cancer. British Medical Journal 289,584–586.
Emery, P. W., Lowell, L. & Rennie, M. J. (1984 b). Protein synthesis measured in vivo in muscle and liver of cachectic tumour-bearing mice. Cancer Research 44,2779–2784.
Fearon, K. C. H., Borland, W., Preston, T., Tisdale, M. J., Shenkin, A. & Calman, K. C. (1988 a). Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. American Journal of Clinical Nutrition 41, 42–48.
Fearon, K. C. H., Hansell, D. T., Preston, T., Plumb, J. A., Davies, J., Shapiro, D., Shenkin, A., Calman, K. C. & Burns, H. J. G. (1988 b). Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer. Cancer Research 48,2590–2595.
Fearon, K. C. H., McMillan, D. C., Preston, T., Hansell, D. T., Shenkin, A. & Garden, O. J. (1991 a). Whole-body protein turnover and the acute-phase protein response in relation to the survival of colon cancer patients. Proceedings of the Nutrition Society 50, 143A.
Fearon, K. C. H., McMillan, D. C., Preston, T., Winstanley, F. P., Cruickshank, A. M. & Shenkin, A. (1991 b). Elevated circulating interleukin-6 is associated with an acute phase response but reduced fixed hepatic protein synthesis in patients with cancer. Annals of Surgery 213, 26–31.
Fearon, K. C. H., Plumb, J. A., Burns, H. J. G & Calman, K. C. (1987). Reduction of the growth rate of the Walker 256 tumour in rats by Rhodamine 6G together with hypoglycaemia. Cancer Research 47,3684–3687.
Fearon, K. C. H., Tisdale, M. J., Preston, T., Plumb, J. A. & Calman, K. C. (1985). Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats. British Journal of Cancer 52,87–92.
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P. & Baumann, H. (1987). Interferon b2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute-phase protein response in liver cells. Proceedings of the National Academy of Sciences, USA 84, 7251–7255.
Gear, A. R. L. (1974). Rhodamine6G. A potent inhibitor of mitochondria1 oxidative phosphorylation. Journal of Biological Chemistry 249,3628–3637.
Glass, R. E., Fern, E. B. & Garlick, P. J. (1983). Whole body protein turnover before and after resection of colorectal turnours. Clinical Science 64, 101–108.
Gough, D. B., Winstanley, F. P., Fearon, K. C. H. & Carter, D. C. (1992). Regulation of TNF production in healthy humans and in patients with cancer. Archives of Surgery (In the Press).
Heber, D., Chlebowski, R. T., Ishibashi, P. E., Herrold, J. N. & Black, J. B. (1982). Abnormalities in glucose and protein metabolism in non-cachectic lung cancer patients. Cancer Research 42, 4815–4819.
Heymsfield, S. B. & McManus, C. B. (1985). Tissue components of weight loss in cancer patients: A new method of study and preliminary observations. Cancer 55,238–249.
Inagaki, J., Rodriguez, V. – Bodey, G. P. (1974). Causes of death in cancer patients. Cancer 33,568–573.
Jeevanandam, M., Lowry, S. F., Horowitz, G. D. & Brennan, M. F. (1984). Cancer cachexia and protein metabolism. Lancet i, 1423–1426.
Lampidis, T. J., Bernal, S. D., Summerhayes, I. C & Chen, L. B. (1983). Selective toxicity of rhodamine 1,2,3 in carcinoma cells in vitro. Cancer Research 43, 716–720.
Langstein, H. N., Doherty, G. M., Fraker, D. L., Buresh, C. M. – Norton, J. A. (1991). The role of Gamma-interferon and turnour necrosis factor a in an experimental rat model of cancer cachexia. Cancer Research 51,2302–2306.
McIntosh, J. K., Jablons, D. M., Mule, J. J., Nordan, R. P., Rudikoff, S., Lotze, M. & Rosenberg, S. A. (1989). In vivo induction of 11–6 by administration of exogenous cytokines and detection of de novo serum levels of II-6 in tumour bearing mice. Journal of Immunology 143, 162–167.
Magee, B. A., Potenzy, N., Rafe, A. M. & Conyers, R. A. J. (1979). The inhibition of malignant cell growth by ketone bodies. hAusiralian Journal of Experimental Biology and Medical Science 51, 529–539.
Miles, J. M. & Hammond, M. W. (1983). 3-Hydroxybutyrate to conserve protein during therapeutic starvation. Lancet i, 409.
Miles, J. M., Nissen, S. L., Rizza, R. A., Gerich, J. E. & Haymond, M. W. (1983). Failure of infused β-hydroxybutyrate to decrease proteolysis in man. Diabetes 32, 197–205.
Nakashima, R. A., Ruggie, M. G. & Pederson, P. L. (1984). Contributions of glycolysis and oxidative phosphorylation to adenosine 5-tryphosphate production in A530-D hepatoma cells. Cancer Research 44, 5702–5706.
Nixon, D. W., Lawson, D. H., Kutner, M., Ansley, J., Schwartz, M., Heymsfield, S., Chawla, R., Cartwnght, T. H. & Rudman, D. (1981). Hyperalimentation of the cancer patient with protein calorie undernutrition. Cancer Research 41, 2038–2045.
Pain, V. M., Randall, D. P. & Garlick, P. J. (1984). Protein synthesis in liver and skeletal muscle of mice bearing an ascites tumour. Cancer Research 44,1054–1057.
Pawan, G. L. S. & Semple, S. J. G. (1983). Effect of 3-hydroxybutyrate in obese subjects on very low energy diets and during therapeutic starvation. Lancet i, 15–17.
Pedersen, P. L. (1978). Tumour mitochondria and the bioenergetics of the cancer cell. Progress in Experimental Tumour Research 22,190–273.
Plumb, J. A., Fearon, K. C. H., Carter, K. B. & Preston, T. (1991). Energy expenditure and protein synthesis rates in an animal model of cancer cachexia. Clinical Nutrition 10, 23–29.
Preston, T., Fearon, K. C. H., Robertson, I., East, B. W. & Calman, K. C. (1987). Tissue loss during severe wasting in lung cancer patients. In In Vivo Body Composition Studies, pp. 60–69 [Ellis, K. J., S., Yasumura and Morgan, W. D. editors]. London: Institute of Physical Sciences in Medicine.
Raynes, J. G. & Cooper, E. H. (1983). Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non malignant disease. Journal of Clinical Pathology 36, 798–803.
Selberg, O., McMillan, D. C., Preston, T., Carse, H., Shenkin, A. & Bums, H. J. G. (1990). Palmitate turnover and its response to glucose infusion in weight-losing cancer patients. Clinical Nutrition 9, 150–156.
Selby, P., Hobbs, S., Viner, C., Jackson, E., Jones, A., Newell, D., Calvert, A. H., McElwain, T., Fearon, K., Humphreys, J. & Shiga, T. (1987). Tumour necrosis factor in man: Clinical and biological observations. British Journal of Cancer 56,803–308.
Sherry, B. A., Gelin, J., Fong, Y., Marano, M., Wei, H., Cerami, A., Lowry, S. F., Lundholm, K. G. & Moldawer, L. L. (1989). Anticachectin-tumour necrosis factor α antibodies attenuate development of cachexia in tumour models. FASEB Journal 3, 1956–1962.
Sherwin, R. S., Hendler, R. G. & Felig, P. (1975). Effect of ketone infusion on amino acid and nitrogen metabolism in man. Journal of Clinical Investigation 55, 1382–1390.
te Velde, A. A., Huikbens, R. J. F., Heije, K., de Vries, J. E. & Figdor, C. G. (1990). Interleukin-4 inhibits secretion of 11–1, TNF and 11–6 by human monocytes. Blood 76, 1392–1397.
Tisdale, M. J. (1982). Tumour and host nutrition. Cancer Topics 3, 113.
Tisdale, M. J. & Brennan, R. A. (1983). Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. British Journal of Cancer 47,293–297.
Tisdale, M. J., Brennan, R. A. & Fearon, K. C. H. (1987). Reduction of weight loss and tumour size in a cachexia model by a high fat diet. British Journal of Cancer 56,39–43.
Warburg, O. (1930). Metabolism of Tumours. Translated by F., Dickens. London: Arnold Constable.
Warren, R. S., Starnes, H. F., Gabrolive, J. L., Oettgen, H. F. & Brennan, M. F. (1987). The acute metabolic effects of tumour necrosis factor administration in humans. Archives of Surgery 122, 1396–1400.
Warren, S. (1932). The immediate causes of death in cancer. American Journal of Medical Science 184, 610–616.
Williams, J. F. & Matthaei, K. I. (1981). Cancer induced body wasting. A review of cancer cachexia and a hypothesis concerning the molecular basis of the condition. Asian Journal of Clinical Science 2, 158–166.